Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT02247635
• Date of registration: 17/09/2014
• Prospective Registration: No
• Primary sponsor: Mexican National Institute of Public Health
• Public title: Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women MPATPCDNC
• Scientific title: Development of a Methodology for Diagnosis and Promoting Adherence to Treatment of Patients With Chronic Diseases and Evaluation of Their Impact on Cardiovascular Risk Factors
• Date of first enrolment: November 2008
• Target sample size: 180
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT02247635
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: N/A

Countries of recruitment

Mexico

Contacts

• Name: Simón Barquera, PhD
• Affiliation: Mexican National Institute of Public Health

Key inclusion & exclusion criteria

Inclusion Criteria:

- Women from 19 to 65 years old

- Body mass index = 25.0 - =39.9 or abdominal obesity

- With previous medical diagnosis:

1. high fasting glucose

2. high blood pressure

3. dyslipidemia.

Exclusion Criteria:

- Currently pregnant or breast-feeding.

- Anxiety and depression significantly.

- Consumption of alcohol or smoking significantly.

- Taking anorexigenic or other weight-loss drugs (Xenical)

- Pregnant or breastfeeding

- Have polycystic ovary syndrome,

- Kidney failure

- Hypothyroidism,

- Cancer,

- Anxiety or depression



Age minimum: 20 Years
Age maximum: 65 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Diabetes

Dyslipidemia

High Blood Pressure

Obesity

Intervention(s)

Behavioral: Healthy lifestyle and adherence

Primary Outcome(s)

Reduction in the prevalence of metabolic syndrome (obesity, diabetes, hypertension, dyslipidemia) [Time Frame: 24 weeks]

Secondary Outcome(s)

Weight loss [Time Frame: 24 weeks]

Reduction of hyperglycemia [Time Frame: 24 weeks]

Reduction of hypercholesterolemia [Time Frame: 24 weeks]

Reduction of high blood pressure [Time Frame: 24 weeks]

Secondary ID(s)

000000000044415

CINYS 410

Source(s) of Monetary Support

Please refer to primary and secondary sponsors